Halozyme Therapeutics Inc. buy Benchmark Co.
Start price
18:30
/
50%
€50.28
Target price
08.08.25
€55.00
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.08.25. The prediction end date can be changed by Benchmark_Co_ at any time.Performance without dividends (%)
Name | 1w |
---|---|
Halozyme Therapeutics Inc. | - |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by Benchmark_Co_ for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $60.00 price target on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.68
25.06.24
25.06.24
€56.00
25.06.25
25.06.25
3.29%
17:58
17:58
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.23
16.04.24
16.04.24
€46.98
16.04.25
16.04.25
37.59%
17:58
17:58
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.35
19.01.24
19.01.24
€45.94
19.01.25
19.01.25
60.38%
17:58
17:58
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.23
20.10.23
20.10.23
€47.17
20.10.24
20.10.24
51.31%
17:58
17:58